| J9271 | Injection, pembrolizumab, 1 mg | 30,600 | $40 | $1.3M |
| J0897 | Injection, denosumab, 1 mg | 13,860 | $20 | $263.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,230 | $90 | $209.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 670 | $100 | $65.9K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 49,500 | $1 | $49.5K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 630 | $60 | $39.7K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 270 | $140 | $36.4K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 5,400 | $10 | $32.4K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 180 | $140 | $24.8K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 140 | $170 | $23.1K |